BRCC3 and acute myeloid leukemia: In a large sequencing study of CBF AML we found recurrent inactivating mutations in BRCC3 in t(8;21)(q22;q22.1) AML with a frequency of 4.7% but not in inv(16)(p13.1q22) AML [30].